GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MedPlus Health Services MEDPLUS.NS · INR

Consumer Staples · NSE · 🇮🇳 India

Compare

596.00

-1.42%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹68.92bn

FY2019FY2026

Net income

₹2.20bn

FY2019FY2026

Free cash flow

₹4.04bn

FY2019FY2026

Shareholders' equity

₹19.75bn

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₹68.92bn₹61.36bn₹56.25bn₹45.58bn₹37.79bn₹30.69bn₹28.71bn₹22.73bn
Research and development—————₹2.1m₹2.5m₹3.0m
Operating income₹3.24bn₹7.26bn₹1.70bn₹1.30bn₹3.85bn₹1.42bn₹967.8m₹691.9m
Net income₹2.20bn₹1.50bn₹654.7m₹497.6m₹958.0m₹638.6m₹21.8m₹119.2m
Diluted earnings per share18.2912.515.454.138.005.650.200.99

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₹39.33bn₹33.60bn₹30.05bn₹27.97bn₹25.94bn₹15.66bn₹13.49bn₹9.59bn
Cash and short-term investments₹4.62bn₹4.40bn₹1.65bn₹2.89bn₹6.58bn₹1.49bn₹1.41bn₹499.1m
Total liabilities₹19.58bn₹16.20bn₹14.27bn₹13.06bn₹11.77bn₹8.35bn₹8.20bn₹6.67bn
Debt₹14.24bn₹11.20bn₹10.10bn₹9.05bn₹8.15bn₹5.90bn₹4.77bn₹4.29bn
Shareholders' equity₹19.75bn₹17.41bn₹15.78bn₹14.91bn₹14.18bn₹7.31bn₹5.28bn₹2.91bn
Shares outstanding120m120m120m120m120m113m108m120m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₹5.27bn₹5.54bn₹1.44bn₹904.1m₹1.70bn₹28.9m−₹65.9m₹1.47bn
Capital spending−₹1.23bn−₹594.5m−₹844.0m−₹1.69bn−₹1.18bn−₹542.6m−₹302.1m−₹217.6m
Free cash flow₹4.04bn₹4.95bn₹593.4m−₹785.9m₹521.7m−₹513.7m−₹368.0m₹1.25bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹18.80bn₹18.64bn₹18.06bn₹16.79bn₹15.43bn₹15.10bn₹15.61bn₹15.76bn
Operating income₹553.2m₹932.3m₹858.8m₹802.8m₹2.02bn₹879.6m₹2.01bn₹1.94bn
Net income₹331.8m₹639.8m₹578.1m₹555.0m₹423.6m₹513.4m₹458.9m₹387.4m
Diluted earnings per share2.765.334.814.623.524.273.823.22
Cash from operations———₹3.13bn————
Capital spending———−₹427.0m————
Free cash flow———₹2.71bn————
Total assets—₹39.33bn—₹35.72bn—₹33.60bn—₹31.55bn
Cash and short-term investments₹6.13bn₹4.62bn₹6.05bn₹5.02bn₹3.67bn₹3.67bn₹2.68bn₹3.03bn
Debt—₹1.91bn—₹1.83bn—₹1.12bn—₹1.11bn
Shareholders' equity₹19.75bn₹19.75bn₹18.44bn₹18.45bn₹17.40bn₹17.41bn₹16.36bn₹16.36bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.8%17.4%—
Operating income35.6%17.9%—
Net income64.0%28.0%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin8.1%5.8%6.2%—
Net margin2.8%2.1%2.1%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings33.464.5152.4181.776.2182.6
Price to sales1.11.61.82.02.03.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.